| 000 | 01710 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514042939.0 | ||
| 264 | 0 | _c20030728 | |
| 008 | 200307s 0 0 eng d | ||
| 022 | _a0268-3369 | ||
| 024 | 7 |
_a10.1038/sj.bmt.1703671 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPassweg, J R | |
| 245 | 0 | 0 |
_aHigh stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation. _h[electronic resource] |
| 260 |
_bBone marrow transplantation _cSep 2002 |
||
| 300 |
_a267-71 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAntigens, CD34 |
| 650 | 0 | 4 |
_aAntilymphocyte Serum _xadministration & dosage |
| 650 | 0 | 4 | _aCD3 Complex |
| 650 | 0 | 4 | _aCell Count |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aGraft Survival |
| 650 | 0 | 4 |
_aHematologic Neoplasms _xmortality |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLymphocyte Depletion |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 |
_aTransplantation Conditioning _xmethods |
| 650 | 0 | 4 |
_aTransplantation, Homologous _xmethods |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMeyer-Monard, S | |
| 700 | 1 | _aGregor, M | |
| 700 | 1 | _aFavre, G | |
| 700 | 1 | _aHeim, D | |
| 700 | 1 | _aEbnoether, M | |
| 700 | 1 | _aTichelli, A | |
| 700 | 1 | _aGratwohl, A | |
| 773 | 0 |
_tBone marrow transplantation _gvol. 30 _gno. 5 _gp. 267-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bmt.1703671 _zAvailable from publisher's website |
| 999 |
_c12090239 _d12090239 |
||